Congress goalsPromote research on rare and orphan diseases among the general public, industry and policy makersBring together researchers and their knowledgeHelping the understanding of other more common diseasesEncourage clear insights positions identifiable from the scientific community in university and industryMain topicsGene and Cell Therapy; Stem CellsDiagnosticsTherapeutic ApplicationsGenomic DisordersScientific disciplines involvedAutoimmunity, biochemistry, cell biology, dermatology, endrocrinology, gastroenterology, gene therapy, human genetic, hematology, infectious diseases, inflammation, molecular and cellular biology, neuroimmunology, oncology, orphan drugs, pathology, pharmacology, primary immune deficiency, rheumatology, transplantation, virology.RARE IS COMMON“What we learn from rare disorders often has profound consequences for our understanding of more common conditions”. Francis S. Collins (M.D., Ph.D., NIH Director).